Gary Ewart

1.8k total citations
24 papers, 1.4k citations indexed

About

Gary Ewart is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Gary Ewart has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 9 papers in Molecular Biology and 9 papers in Virology. Recurrent topics in Gary Ewart's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and Animal Virus Infections Studies (5 papers). Gary Ewart is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and Animal Virus Infections Studies (5 papers). Gary Ewart collaborates with scholars based in Australia, United States and Thailand. Gary Ewart's co-authors include Peter W. Gage, G B Cox, Lauren E. Wilson, Tara D. Sutherland, Carolyn A. Luscombe, Michelle Miller, John Wilkinson, Kerry Mills, Ronald C. Weir and Philip G. Board and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Virology.

In The Last Decade

Gary Ewart

24 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary Ewart Australia	15	702	477	364	331	230	24	1.4k
Masashi Tatsumi Japan	18	474 0.7×	335 0.7×	544 1.5×	148 0.4×	41 0.2×	63	1.1k
Zene Matsuda Japan	24	1.1k 1.6×	689 1.4×	1.1k 3.0×	458 1.4×	69 0.3×	47	2.3k
Christian Castro United States	14	371 0.5×	634 1.3×	88 0.2×	295 0.9×	79 0.3×	23	1.2k
Simon P. Tucker United States	20	298 0.4×	313 0.7×	207 0.6×	414 1.3×	60 0.3×	34	1.0k
Selena M. Sagan Canada	22	478 0.7×	850 1.8×	54 0.1×	394 1.2×	130 0.6×	61	1.8k
Tijana Ivanovic United States	15	350 0.5×	274 0.6×	106 0.3×	256 0.8×	82 0.4×	18	746
Fernando Valiente‐Echeverría Chile	24	447 0.6×	710 1.5×	271 0.7×	112 0.3×	34 0.1×	54	1.3k
Yonggang Li China	18	361 0.5×	235 0.5×	79 0.2×	267 0.8×	96 0.4×	63	1.1k
Stephen W. Mason Canada	21	494 0.7×	921 1.9×	470 1.3×	309 0.9×	42 0.2×	31	1.7k
Arno L. W. van Vliet Netherlands	19	553 0.8×	333 0.7×	95 0.3×	242 0.7×	299 1.3×	24	1.1k

Countries citing papers authored by Gary Ewart

Since Specialization

Citations

This map shows the geographic impact of Gary Ewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Ewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Ewart more than expected).

Fields of papers citing papers by Gary Ewart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Ewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Ewart. The network helps show where Gary Ewart may publish in the future.

Co-authorship network of co-authors of Gary Ewart

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Ewart. A scholar is included among the top collaborators of Gary Ewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Ewart. Gary Ewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ewart, Gary, Michael Bobardt, Bo Hjorth Bentzen, et al.. (2023). Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of K18-hACE2 transgenic mice infected with a lethal dose of SARS-CoV-2. PLoS Pathogens. 19(8). e1011328–e1011328. 7 indexed citations

Luscombe, Carolyn A., Anchalee Avihingsanon, Khuanchai Supparatpinyo, et al.. (2020). Human Immunodeficiency Virus Type 1 Vpu Inhibitor, BIT225, in Combination with 3-Drug Antiretroviral Therapy: Inflammation and Immune Cell Modulation. The Journal of Infectious Diseases. 223(11). 1914–1922. 14 indexed citations

Khoury, Gabriela, Gary Ewart, Carolyn A. Luscombe, Michelle Miller, & John Wilkinson. (2016). The antiviral compound BIT225 inhibits HIV-1 replication in myeloid dendritic cells. AIDS Research and Therapy. 13(1). 7–7. 8 indexed citations

Taylor, Adam, Lara J. Herrero, Bastian Thaa, et al.. (2016). Effects of an In-Frame Deletion of the 6k Gene Locus from the Genome of Ross River Virus. Journal of Virology. 90(8). 4150–4159. 38 indexed citations

Wilkinson, John, Gary Ewart, Carolyn A. Luscombe, et al.. (2015). A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection. Journal of Antimicrobial Chemotherapy. 71(3). 731–738. 13 indexed citations

Luscombe, Carolyn A., Zhuhui Huang, Michael G. Murray, et al.. (2010). A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-α-2b and nucleoside analogues. Antiviral Research. 86(2). 144–153. 74 indexed citations

Patargias, George, Gary Ewart, Carolyn A. Luscombe, & Wolfgang B. Fischer. (2010). Ligand-protein docking studies of potential HIV-1 drug compounds using the algorithm FlexX. Analytical and Bioanalytical Chemistry. 396(7). 2559–2563. 7 indexed citations

Rulli, Nestor E., et al.. (2007). The Molecular and Cellular Aspects of Arthritis Due to Alphavirus Infections. Annals of the New York Academy of Sciences. 1102(1). 96–108. 59 indexed citations

Haqshenas, Gholamreza, Xuebin Dong, Gary Ewart, S. Bowden, & Eric J. Gowans. (2006). A 2a/1b full-length p7 inter-genotypic chimeric genome of hepatitis C virus is infectious in vitro. Virology. 360(1). 17–26. 18 indexed citations

10.

Wilson, Lauren E., Peter W. Gage, & Gary Ewart. (2006). Validation of Coronavirus E Proteins Ion Channels as Targets for Antiviral Drugs. Advances in experimental medicine and biology. 581. 573–578. 1 indexed citations

11.

Wilson, Lauren E., Peter W. Gage, & Gary Ewart. (2006). Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication. Virology. 353(2). 294–306. 161 indexed citations

12.

Ewart, Gary, et al.. (2004). An Amino-Acid Substitution in the Influenza-B NB Protein Affects Ion-Channel Gating. The Journal of Membrane Biology. 197(3). 135–143. 7 indexed citations

13.

Wilson, Lauren E., et al.. (2004). SARS coronavirus E protein forms cation-selective ion channels. Virology. 330(1). 322–331. 219 indexed citations

14.

Ewart, Gary, Najla Nasr, Hassan M. Naif, et al.. (2004). Potential New Anti-Human Immunodeficiency Virus Type 1 Compounds Depress Virus Replication in Cultured Human Macrophages. Antimicrobial Agents and Chemotherapy. 48(6). 2325–2330. 47 indexed citations

15.

Ewart, Gary, Kerry Mills, G B Cox, & Peter W. Gage. (2002). Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu. European Biophysics Journal. 31(1). 26–35. 94 indexed citations

16.

Ewart, Gary, et al.. (2002). Alphavirus 6K Proteins Form Ion Channels. Journal of Biological Chemistry. 277(49). 46923–46931. 101 indexed citations

17.

Robinson, Anna, et al.. (2000). Structure of the C123S mutant of dienelactone hydrolase (DLH) bound with the PMS moiety of the protease inhibitor phenylmethylsulfonyl fluoride (PMSF). Acta Crystallographica Section D Biological Crystallography. 56(11). 1376–1384. 11 indexed citations

18.

Ewart, Gary, et al.. (1996). Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers.. Proceedings of the National Academy of Sciences. 93(1). 111–115. 102 indexed citations

19.

Ewart, Gary & G. Smith. (1989). Purification and properties of soluble hydrogenase from the cyanobacterium Anabaena cylindrica. Archives of Biochemistry and Biophysics. 268(1). 327–337. 17 indexed citations

20.

Ewart, Gary & G. Smith. (1989). Immunochemical analysis of the soluble hydrogenase from the cyanobacterium Anabaena cylindrica. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 997(1-2). 83–89. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact